Morey & Quinn Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462K Sell
1,275
-8
-0.6% -$2.74K 0.3% 81
2026
Q1
$451K Hold
1,283
0.32% 78
2025
Q4
$420K Sell
1,283
-1
-0.1% -$317 0.3% 82
2025
Q3
$362K Buy
1,284
+1
+0.1% +$290 0.27% 88
2025
Q2
$358K Sell
1,283
-156
-11% -$44.2K 0.29% 86
2025
Q1
$448K Buy
1,439
+2
+0.1% +$591 0.37% 66
2024
Q4
$375K Buy
+1,437
New +$426K 0.32% 77

Other funds holding AMGN

Morey & Quinn Wealth Partners's AMGN Position: Q2 2026 in Review

Morey & Quinn Wealth Partners reduced its Amgen (AMGN) stake by 0.62% in Q2 2026, selling an estimated $2.74K and leaving 1,275 shares worth $462K. The position accounts for 0.3% of the portfolio, ranked #81.

Morey & Quinn Wealth Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Morey & Quinn Wealth Partners held 1,275 shares of Amgen worth $462K as of Q2 2026.
  • Morey & Quinn Wealth Partners sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
  • Amgen made up 0.3% of Morey & Quinn Wealth Partners's portfolio in Q2 2026, its #81 holding.
  • Morey & Quinn Wealth Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Morey & Quinn Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.